Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001373604-25-000090
Filing Date
2025-06-16
Accepted
2025-06-16 15:40:59
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3624
  Complete submission text file 0001373604-25-000090.txt   5002
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address
Leonard Braden Michael (Reporting) CIK: 0001373603 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 251049878

Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)